{"id":"https://openalex.org/W1925463932","doi":"https://doi.org/10.4009/jsdt.46.923","title":"An examination of switching from insulin to glucagon-like peptide-1 analogue liraglutide in hemodialysis patients with type 2 diabetes: A descriptive epidemiology study","display_name":"An examination of switching from insulin to glucagon-like peptide-1 analogue liraglutide in hemodialysis patients with type 2 diabetes: A descriptive epidemiology study","publication_year":2013,"publication_date":"2013-01-01","ids":{"openalex":"https://openalex.org/W1925463932","doi":"https://doi.org/10.4009/jsdt.46.923","mag":"1925463932"},"language":"en","primary_location":{"id":"doi:10.4009/jsdt.46.923","doi":"https://doi.org/10.4009/jsdt.46.923","is_oa":true,"landing_page_url":"https://doi.org/10.4009/jsdt.46.923","pdf_url":"https://www.jstage.jst.go.jp/article/jsdt/46/9/46_923/_pdf","source":{"id":"https://openalex.org/S193646740","display_name":"Nihon Toseki Igakkai Zasshi","issn_l":"1340-3451","issn":["1340-3451","1883-082X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4324113252","host_organization_name":"Japanese Society for Dialysis Therapy","host_organization_lineage":["https://openalex.org/P4324113252"],"host_organization_lineage_names":["Japanese Society for Dialysis Therapy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon Toseki Igakkai Zasshi","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jsdt/46/9/46_923/_pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067659773","display_name":"Ryuji Matsushita","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ryuji Matsushita","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079384517","display_name":"Shotaro Taniguchi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shotaro Taniguchi","raw_affiliation_strings":["Miyazaki Prefectural Health Foundation\uff1b"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Miyazaki Prefectural Health Foundation\uff1b","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012213409","display_name":"Keiichi Matsuzaki","orcid":"https://orcid.org/0000-0002-2113-1574","observed_orcids":["https://orcid.org/0000-0002-2113-1574"]},"institutions":[{"id":"https://openalex.org/I22299242","display_name":"Kyoto University","ror":"https://ror.org/02kpeqv85","country_code":"JP","type":"education","lineage":["https://openalex.org/I22299242"]},{"id":"https://openalex.org/I34077901","display_name":"Juntendo University","ror":"https://ror.org/01692sz90","country_code":"JP","type":"education","lineage":["https://openalex.org/I34077901"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Keiichi Matsuzaki","raw_affiliation_strings":["Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine\uff1b","Kyoto University Health Service\uff1b"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine\uff1b","institution_ids":["https://openalex.org/I34077901"]},{"raw_affiliation_string":"Kyoto University Health Service\uff1b","institution_ids":["https://openalex.org/I22299242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067563478","display_name":"Yoshiyuki Furumatsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I98285908","display_name":"The University of Osaka","ror":"https://ror.org/035t8zc32","country_code":"JP","type":"education","lineage":["https://openalex.org/I98285908"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yoshiyuki Furumatsu","raw_affiliation_strings":["Department of Health Economics and Industrial Policy, Osaka University Graduate School of Medicine\uff1b","Fujiidera Keijinkai Clinic"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Health Economics and Industrial Policy, Osaka University Graduate School of Medicine\uff1b","institution_ids":["https://openalex.org/I98285908"]},{"raw_affiliation_string":"Fujiidera Keijinkai Clinic","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111507443","display_name":"Yumiko Yanagihara","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yumiko Yanagihara","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010514871","display_name":"Kazuko Harada","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kazuko Harada","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039237165","display_name":"Koujin Nakayama","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Koujin Nakayama","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006328463","display_name":"Kaori Kato","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kaori Kato","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064492204","display_name":"Tomonori Nakashima","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tomonori Nakashima","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060156624","display_name":"Shuji Nakamura","orcid":"https://orcid.org/0000-0001-6286-884X","observed_orcids":["https://orcid.org/0000-0001-6286-884X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Shuji Nakamura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5047129696","display_name":"Masanao Nagatomo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Masanao Nagatomo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"46","issue":"9","first_page":"923","last_page":"929"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10291","display_name":"Dialysis and Renal Disease Management","score":0.002099999925121665,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/liraglutide","display_name":"liraglutide","score":0.9660000205039978},{"id":"https://openalex.org/keywords/insulin-switching","display_name":"insulin switching","score":0.7570000290870667},{"id":"https://openalex.org/keywords/glp-1-receptor-agonists","display_name":"GLP-1 receptor agonists","score":0.9070000052452087},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9710000157356262},{"id":"https://openalex.org/keywords/hemodialysis","display_name":"hemodialysis","score":0.906000018119812},{"id":"https://openalex.org/keywords/glycated-albumin","display_name":"glycated albumin","score":0.7950000166893005},{"id":"https://openalex.org/keywords/endogenous-insulin-secretion","display_name":"endogenous insulin secretion","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hypoglycemia","display_name":"hypoglycemia","score":0.8529999852180481},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.8859999775886536},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.6140000224113464},{"id":"https://openalex.org/keywords/c-peptide","display_name":"C-peptide","score":0.5019999742507935},{"id":"https://openalex.org/keywords/insulin-dose-reduction","display_name":"insulin dose reduction","score":0.34599998593330383},{"id":"https://openalex.org/keywords/treatment-discontinuation","display_name":"treatment discontinuation","score":0.36500000953674316},{"id":"https://openalex.org/keywords/nephrotoxicity","display_name":"nephrotoxicity","score":0.45399999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9394036531448364},{"id":"https://openalex.org/C2781308992","wikidata":"https://www.wikidata.org/wiki/Q2526479","display_name":"Liraglutide","level":4,"score":0.9276712536811829},{"id":"https://openalex.org/C2778063415","wikidata":"https://www.wikidata.org/wiki/Q391744","display_name":"Hemodialysis","level":2,"score":0.6846485137939453},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5915746092796326},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5312309861183167},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.484077125787735},{"id":"https://openalex.org/C107130276","wikidata":"https://www.wikidata.org/wiki/Q133805","display_name":"Epidemiology","level":2,"score":0.48229363560676575},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4622909724712372},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.4447769522666931},{"id":"https://openalex.org/C2778563252","wikidata":"https://www.wikidata.org/wiki/Q170617","display_name":"Glucagon","level":3,"score":0.42727231979370117},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.42275339365005493}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4009/jsdt.46.923","doi":"https://doi.org/10.4009/jsdt.46.923","is_oa":true,"landing_page_url":"https://doi.org/10.4009/jsdt.46.923","pdf_url":"https://www.jstage.jst.go.jp/article/jsdt/46/9/46_923/_pdf","source":{"id":"https://openalex.org/S193646740","display_name":"Nihon Toseki Igakkai Zasshi","issn_l":"1340-3451","issn":["1340-3451","1883-082X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4324113252","host_organization_name":"Japanese Society for Dialysis Therapy","host_organization_lineage":["https://openalex.org/P4324113252"],"host_organization_lineage_names":["Japanese Society for Dialysis Therapy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon Toseki Igakkai Zasshi","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4009/jsdt.46.923","doi":"https://doi.org/10.4009/jsdt.46.923","is_oa":true,"landing_page_url":"https://doi.org/10.4009/jsdt.46.923","pdf_url":"https://www.jstage.jst.go.jp/article/jsdt/46/9/46_923/_pdf","source":{"id":"https://openalex.org/S193646740","display_name":"Nihon Toseki Igakkai Zasshi","issn_l":"1340-3451","issn":["1340-3451","1883-082X"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4324113252","host_organization_name":"Japanese Society for Dialysis Therapy","host_organization_lineage":["https://openalex.org/P4324113252"],"host_organization_lineage_names":["Japanese Society for Dialysis Therapy"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nihon Toseki Igakkai Zasshi","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1925463932.pdf","grobid_xml":"https://content.openalex.org/works/W1925463932.grobid-xml"},"referenced_works_count":9,"referenced_works":["https://openalex.org/W390818239","https://openalex.org/W2012425163","https://openalex.org/W2040643300","https://openalex.org/W2071835038","https://openalex.org/W2109451951","https://openalex.org/W2122413504","https://openalex.org/W2140536043","https://openalex.org/W2153503875","https://openalex.org/W2225351163"],"related_works":["https://openalex.org/W2316003308","https://openalex.org/W2742243122","https://openalex.org/W3154282562","https://openalex.org/W2743461490","https://openalex.org/W2617830154","https://openalex.org/W2002717252","https://openalex.org/W7208351724","https://openalex.org/W2254276957","https://openalex.org/W7007200602","https://openalex.org/W7143963429"],"abstract_inverted_index":{"\u76ee\u7684\uff1a\u900f\u6790\u60a3\u8005\u306e\u8840\u7cd6\u7ba1\u7406\u306b\u306f\u30a4\u30f3\u30b9\u30ea\u30f3\u4ee5\u5916\u306e\u9078\u629e\u80a2\u304c\u4e4f\u3057\u304f\uff0c\u5185\u56e0\u6027\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u304c\u4fdd\u6301\u3055\u308c\u3066\u3044\u3066\u3082\uff0c\u3084\u3080\u3092\u5f97\u305a\u30a4\u30f3\u30b9\u30ea\u30f3\u4f7f\u7528\u3057\u3066\u3044\u308b\u75c7\u4f8b\u304c\u5b58\u5728\u3059\u308b\uff0e1\u65e51\u56de\u306e\u76ae\u4e0b\u6ce8\u5c04\u3067\u6295\u4e0e\u3059\u308bGlucagon":[0],"like":[1],"peptide-1\u53d7\u5bb9\u4f53\u4f5c\u52d5\u85ac\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u306f\u8840\u7cd6\u4f9d\u5b58\u6027\u306e\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u3092\u4fc3\u3059\u3053\u3068\u304b\u3089\u4f4e\u8840\u7cd6\u3092\u304d\u305f\u3057\u306b\u304f\u304f\uff0c\u900f\u6790\u60a3\u8005\u306e\u8840\u7cd6\u7ba1\u7406\u306b\u5b89\u5168\u30fb\u6709\u7528\u3067\u3042\u308b\u53ef\u80fd\u6027\u304c\u3042\u308b\uff0e\u30a4\u30f3\u30b9\u30ea\u30f3\u304b\u3089\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u3078\u5207\u308a\u66ff\u3048\u304c\u53ef\u80fd\u3067\u3042\u308c\u3070\u4f4e\u8840\u7cd6\u3084\u6ce8\u5c04\u56de\u6570\u304c\u6e1b\u308b\u306a\u3069\u306e\u30e1\u30ea\u30c3\u30c8\u304c\u3042\u308b\u3068\u8003\u3048\u3089\u308c\u308b\u304c\uff0c\u305d\u306e\u5831\u544a\u306f\u307e\u3060\u5c11\u306a\u3044\uff0e\u308f\u308c\u308f\u308c\u306f\u30a4\u30f3\u30b9\u30ea\u30f3\u304b\u3089\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u3078\u306e\u5207\u308a\u66ff\u3048\u3092\u884c\u3063\u305f2\u578b\u7cd6\u5c3f\u75c5\u900f\u6790\u60a3\u8005\u306e\u81e8\u5e8a\u60c5\u5831\u3092\u96c6\u8a08\u30fb\u89e3\u6790\u3057\u305f\uff0e\u5bfe\u8c61\u3068\u65b9\u6cd5\uff1a\uff3b\u7814\u7a76\u30c7\u30b6\u30a4\u30f3\uff3d\u5358\u65bd\u8a2d\u306b\u304a\u3051\u308b\u8a18\u8ff0\u75ab\u5b66\u7684\u7814\u7a76\uff08\u75c7\u4f8b\u96c6\u7a4d\u7814\u7a76\uff09\uff0e\uff3b\u5bfe\u8c61\uff3d2010\u5e749\u6708\uff5e2011\u5e744\u6708\u306e\u5e73\u548c\u53f0\u75c5\u9662\u5916\u6765\u900f\u6790\u60a3\u800548\u540d\u306e\u3046\u3061\uff0c\u98df\u4e8b\u8ca0\u8377\u8a66\u9a13\u306b\u3066\u7a7a\u8179\u6642\u8840\u6e05C-peptide":[2],"immunoreactivity\uff08s-CPR\uff091.0":[3],"ng/mL\u4ee5\u4e0a\uff0c\u304b\u3064\u98df\u5f8c2\u6642\u9593s-CPR":[4],"4.0":[5],"ng/mL\u4ee5\u4e0a\u3067\u30a4\u30f3\u30b9\u30ea\u30f3\u4f7f\u7528\u4e2d\u306e2\u578b\u7cd6\u5c3f\u75c5\u60a3\u800510\u4f8b\uff0e\uff3b\u4e3b\u306a\u8981\u56e0\uff3d\u30a4\u30f3\u30b9\u30ea\u30f3\u304b\u3089\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u3078\u306e\u5207\u308a\u66ff\u3048\uff0e\uff3b\u4e3b\u306a\u8a55\u4fa1\u9805\u76ee\uff3d\u5207\u308a\u66ff\u30483\u304b\u6708\u5f8c\u306e\u30b0\u30ea\u30b3\u30a2\u30eb\u30d6\u30df\u30f3\uff08GA\uff09\u5024\uff0e\u7d50\u679c\uff1a10\u4f8b\u4e2d3\u4f8b\u304c\u5410\u6c17\u30fb\u5614\u5410\u306e\u305f\u3081\uff0c2\u4f8b\u304c\u9ad8\u8840\u7cd6\u306e\u305f\u3081\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u4e2d\u6b62\u3068\u306a\u3063\u305f\uff0e1\u4f8b\u3067\u75c7\u5019\u6027\u4f4e\u8840\u7cd6\u3092\u8a8d\u3081\u305f\u304c\u88dc\u98df\u3067\u901f\u3084\u304b\u306b\u6539\u5584\u3057\u305f\uff0e\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u7d99\u7d9a\u304c\u53ef\u80fd\u3067\u3042\u3063\u305f5\u4f8b\u3067\u306f\uff0cGA\u5024\u306f\u5207\u308a\u66ff\u3048\u6642\u306e21.8\u00b13.3\uff05\u304b\u3089\u5207\u308a\u66ff\u30483\u304b\u6708\u5f8c\u306b\u306f19.6\u00b11.9\uff05\u3078\u3068\u4f4e\u4e0b\u3057\u3066\u3044\u305f\u304c\u6709\u610f\u5dee\u306f\u8a8d\u3081\u306a\u304b\u3063\u305f\uff0e\u7d50\u8ad6\uff1a\u5410\u6c17\u30fb\u5614\u5410\u304c\u51fa\u73fe\u3057\u3084\u3059\u3044\u53ef\u80fd\u6027\u304c\u3042\u308a\u614e\u91cd\u6295\u4e0e\u304c\u5fc5\u8981\u3060\u304c\uff0c\u5185\u56e0\u6027\u30a4\u30f3\u30b9\u30ea\u30f3\u5206\u6ccc\u304c\u4fdd\u6301\u3055\u308c\u305f2\u578b\u7cd6\u5c3f\u75c5\u900f\u6790\u60a3\u8005\u306b\u304a\u3044\u3066\uff0c\u30a4\u30f3\u30b9\u30ea\u30f3\u304b\u3089\u30ea\u30e9\u30b0\u30eb\u30c1\u30c9\u3078\u306e\u5207\u308a\u66ff\u3048\u306f\u4e00\u3064\u306e\u9078\u629e\u80a2\u3068\u306a\u308a\u5f97\u308b\u3068\u8003\u3048\u3089\u308c\u305f\uff0e":[6]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2016-06-24T00:00:00"}